Exact Mass: 387.0218
Exact Mass Matches: 387.0218
Found 91 metabolites which its exact mass value is equals to given mass value 387.0218,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Thifensulfuron-methyl
CONFIDENCE standard compound; EAWAG_UCHEM_ID 124 CONFIDENCE standard compound; INTERNAL_ID 3688
dCDP
dCDP is a substrate for Uridine-cytidine kinase 1, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Ribonucleoside-diphosphate reductase large subunit, Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase 7, Ribonucleoside-diphosphate reductase M2 chain, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase 6 and UMP-CMP kinase. [HMDB]. dCDP is found in many foods, some of which are oil palm, sweet bay, garden onion (variety), and italian sweet red pepper. dCDP is a substrate for Uridine-cytidine kinase 1, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Ribonucleoside-diphosphate reductase large subunit, Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase 7, Ribonucleoside-diphosphate reductase M2 chain, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase 6 and UMP-CMP kinase. Acquisition and generation of the data is financially supported in part by CREST/JST.
Glucobrassicanapin
Isolated from rape (Brassica napus) and other Brassica species Glucobrassicanapin is found in many foods, some of which are swede, chinese mustard, chinese cabbage, and horseradish. Glucobrassicanapin is found in brassicas. Glucobrassicanapin is isolated from rape (Brassica napus) and other Brassica sp.
benzylhydrochlorothiazide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic Same as: D01246
1-Pentenyl glucosinolate
1-Pentenyl glucosinolate is found in brassicas. 1-Pentenyl glucosinolate is present in brassica Present in brassicas. 1-Pentenyl glucosinolate is found in brassicas.
5'-Hydroxylornoxicam
5-Hydroxylornoxicam is a metabolite of Tenoxicam. 5-hydroxylornoxicam belongs to the family of Thienothiazines. These are heterocyclic compounds containing a thiophene ring fused to a thiazine.
3',4'-Dichlorobenzamil
2-Amino-5-[[1-[carboxymethyl(sulfo)amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
2-{2-[3,5-Bis(trifluoromethyl)phenyl]hydrazono}-2-(propylsulfonyl)acetonitrile
glutathioselenol
A glutathione derivative that is glutathione in which the hydrogen attached to the sulfur is replaced by a selenol group.
5-Hydroxylornoxicam
1-Pentenyl glucosinolate
Thiazolidine, 3-[(2,5-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 2-(4-methylphenyl)-3-[[3-(trifluoromethyl)phenyl]sulfonyl]- (9CI)
5-bromo-3-[5-(morpholin-4-ylmethyl)-1H-pyridin-2-ylidene]-1H-indol-2-one
N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-5-fluoro-2-methylsulfonylaniline
Thiazolidine, 3-[(3,4-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Benzenesulfonamide,N-(2,4-dinitro-1-naphthalenyl)-4-methyl-
3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
Ethylenediaminetetraacetate-copper-ammonia complex
3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide
2-CYANO-N-CYCLOPROPYL-N-((2-FLUORO-4-IODOPHENYL)CARBAMOYL)ACETAMIDE
6-amino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione
ISOPROPYL (2-IODO-4-METHYL-5-(TRIFLUOROMETHYL)PHENYL)CARBAMATE
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one
Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-
tert-butyl 2-amino-5-iodo-4-(trifluoromethyl)benzoate
O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate
4-[4-Bromo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]phenoxy]benzonitrile
(4-chlorophenyl)-(3-methyl-1,3-benzothiazol-3-ium-2-yl)diazene,perchlorate
IMidazo[1,2-d][1,4]benzoxazepine, 9-bromo-5,6-dihydro-2-[3-Methyl-1-(1-Methylethyl)-1H-1,2,4-triazol-5-yl]-
Bromotris(dimethylamino)phosphonium hexafluorophosphate
3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide
6-[(3-Methoxyphenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone
2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide
5-(1H-benzimidazol-2-ylmethylidene)-3-(2-naphthalenyl)-2-sulfanylidene-4-thiazolidinone
2,3-Dihydroxybutanedioic acid--3-(5-nitrofuran-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole (1/1)
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(6-oxobenzo[c]chromen-3-yl)oxyoxane-2-carboxylate
[(2R,3S,4R,5S)-5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Glucobrassicanapin
An alkenylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose having a 6-[(sulfooxy)imino]hex-1-en-6-yl group attached to the anomeric sulfur.
N-(4-bromo-2-methylphenyl)-3-(1,3-dioxo-2-pyrrolo[3,4-c]pyridinyl)propanamide
3,5-diamino-N-[amino-[(2,4-dichlorophenyl)methylimino]methyl]-6-chloro-2-pyrazinecarboxamide
2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide
1-(2-furanylmethyl)-N-[2-(methylthio)-1,3-benzothiazol-6-yl]-5-oxo-3-pyrrolidinecarboxamide
N-{3-[3-(5-bromo-2-methoxyphenyl)acryloyl]phenyl}propanamide
[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[5-(2-amino-5-carbamoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate
Deoxycytidine diphosphate
A 2-deoxycytidine phosphate that is the 2- deoxy derivative of cytidine 5-diphosphate (CDP).
CCMI
CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction[1].
ERK5-IN-2
ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. ERK5-IN-2 does not interact with the BRD4 bromodomain. ERK5-IN-2 suppresses both tumor xenograft growth and basic fibroblast growth factor (bFGF) driven Matrigel plug angiogenesis[1].
